Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

EMA's CHMP backs key drugs from KalVista, Biogen & Ionis for conditions like hereditary angioedema & postpartum depression.

Biogen is ramping up in RTP with a fresh $2 billion investment. © 2025 American City Business Journals. All rights reserved.

Biogen said a key European regulatory committee has recommended approval of its Zurzuvae treatment for women with postpartum depression. Biogen on Friday said a green light would make Zurzuvae the ...

Governor Maura Healey on Friday named four new members to the restructured state agency charged with keeping health care ...

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some ...

The commercial license will become effective upon completion of the transition of commercial rights from Biogen back to ...

The news generated immediate criticism from other industry players and advocates who argued that his appointment could ...

Four months after giving Eli Lilly’s Alzheimer’s disease treatment  a thumbs down, Europe’s Committee for Medicinal Products ...

Massachusetts Governor Healey appoints six to the Health Policy Commission to enhance healthcare affordability.

After several days of fielding criticism about the move behind the scenes, Gov. Maura Healey on Friday plans to name Steve ...